[1] ZHOU W C, ZHANG Q B, QIAO L. Pathogenesis of liver cirrhosis[J]. World J Gastroenterol, 2014,20(23):7312-7324. [2] ABRAMOVITCH S, DAHAN-BACHAR L, SHARVIT E, et al. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats[J]. Gut, 2011, 60(12):1728-1737. [3] NGUYEN L A, HORUZSKO A. Kupffer cell metabolism and function[J]. Enzymol Metab, 2015,1(1):101. [4] CONSIGLIO M, DESTEFANIS M, MORENA D, et al. The vitamin D receptor inhibits the respiratory chain, contributing to the metabolic switch that is essential for cancer cell proliferation[J]. PLoS One, 2014, 9(12):e115816. [5] 呼德尔朝鲁.外源性维生素D3缓解运动诱发的慢性疲劳综合症及其骨骼肌抗氧化系统的影响与分子机制探讨[D]. 西安:陕西师范大学,2014. [6] BROWN K, XIE S, QIU X L, et al. SIRT3 reverses aging-associated degeneration[J]. Cell Rep, 2013, 3(2):319-327. [7] LI Y H, CHOI D H, LEE E H, et al. Sirtuin 3(SIRT3) regulates α-smooth muscle actin (α-SMA) production through the succinate dehydrogenase-G protein-coupled receptor 91(GPR91) pathway in hepatic stellate cells[J]. J Biol Chem, 2016, 291(19):10277-10292. [8] FAN Y G, GUO T, HAN X R, et al. Paricalcitol accelerates BACE1 lysosomal degradation and inhibits calpain-1 dependent neuronal loss in APP/PS1 transgenic mice[J]. EBio Medicine, 2019, 45:393-407. [9] 徐列明, 刘平, 沈锡中, 等. 肝纤维化中西医结合诊疗指南(2019年版)[J]. 中国中西医结合杂志, 2019, 39(11):1286-1295. [10] LI R, LIU Y, XIE J, et al. Sirt3 mediates the protective effect of hydrogen in inhibiting ROS-induced retinal senescence[J]. Free Rad Biol Med, 2019, 135:116-124. [11] WILHELM A, ALDRIDGEL V, HALDAR D, et al. CD248/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanism[J]. Gut, 2016, 65(7):1175-1185. [12] LIA D, REYES A, MELO CAMPOS, et al. Mitochondrial maintenance under oxidative stress depends on mitochondrially localised α-OGG1[J]. J Cell Sci, 2018.DOI:10.1242/jcs,213538. [13] ZHANG C Y, YUAN W G, HE P, et al. Liver fibrosis and hepatic stellate cells:etiology, pathological hallmarks and therapeutic targets[J]. World J Gastroenterol, 2016, 22(48):10512-10522. [14] BENEDICT M, ZHANG X. Non-alcoholic fatty liver disease:An expanded review[J]. J Hepatol, 2017, 9(16):715-732. [15] DING N, YU R T, SUBRAMANIAM N, et al. A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response[J]. Cell, 2013, 153(3):601-613. [16] DURAN A, HERNANDEZ E D, REINA-CAMPOS M, et al. P62/SQSTM1 by binding to vitamin D receptor inhibits hepatic stellate cell activity, fibrosis, and liver cancer[J]. Cancer Cell, 2016, 30(4):595-609. [17] QUE R, SHEN Y, REN J, et al. Estrogen receptor β dependent effects of saikosaponin D on the suppression of oxidative stress induced rat hepatic stellate cell activation[J]. Int J Mol Med, 2017, 41(3):1357-1364. [18] YAO T B, YING X Y, ZHAO Y C, et al. Vitamin D receptor activation protects against myocardial reperfusion injury through inhibition of apoptosis and modulation of autophagy[J]. Antioxid Redox Signal, 2015, 22(8):633-650. [19] ZHANG M J, LIN L M, XU C S, et al. VDR agonist prevents diabetic endothelial dysfunction through inhibition of prolyl isomerase-1-mediated mitochondrial oxidative stress and inflammation[J]. Oxid Med Cell Longev, 2018, 2018:1714896. [20] CHEN L L, YANG R L, QIAO W X, et al. 1, 25-Dihydroxyvitamin D exerts an antiaging role by activation of Nrf2-antioxidant signaling and inactivation of p16/p53-senescence signaling[J]. Aging Cell, 2019, 18(3):e12951. [21] LEE S M, MEYER M B, BENKUSKY N A, et al. The impact of VDR expression and regulation in vivo[J]. J Steroid Biochem Mol Biol, 2018, 177:36-45. [22] LA MARRA F, STINCO G, BULIGAN C, et al. Immunohistochemical evaluation of vitamin D receptor (VDR) expression in cutaneous melanoma tissues and four VDR gene polymorphisms[J]. Cancer Biol Med, 2017, 14(2):162-175. [23] FIRRINCIELI D, ZUÑIGA S, REY C, et al. Vitamin D nuclear receptor deficiency promotes cholestatic liver injury by disruption of biliary epithelial cell junctions in mice[J]. Hepatology, 2013, 58(4):1401-1412. [24] KEANE J T, ELANGOVAN H, STOKES R A, et al. Vitamin D and the liver-correlation or cause?[J]. Nutrients, 2018, 10(4):496. [25] 刘智勇,朱泽民.肝脏巨噬细胞中维生素D受体的激活可以阻止小鼠肝脏内质网的应激[J].临床肝胆病杂志,2019,35(10):2364. [26] 李霞, 王彦方, 陈战巧, 等. 沉默信息调节因子3在丹酚酸A抗紫外线诱导视网膜色素上皮细胞氧化应激性损伤中的作用及机制[J]. 温州医科大学学报, 2019, 49(4):272-276. [27] CHENARI S, SAFARI F, MORADI A. Curcumin enhances liver SIRT3 expression in the rat model of cirrhosis[J]. Iran J Basic Med Sci, 2017, 20(12):1306-1311. [28] CHENG Y H, DAI C, ZHANG J. SIRT3-SOD2-ROS pathway is involved in linalool-induced glioma cell apoptotic death[J]. Acta Biochim Pol, 2017, 64(2):343-350. [29] CHEN Y, QING W, SUN M, et al. Melatonin protects hepatocytes against bile acid-induced mitochondrial oxidative stress via the AMPK-SIRT3-SOD2 pathway[J]. Free Radic Res, 2015, 49(10):1275-1284. [30] LIU X H, ZHANG L, WANG P, et al. Sirt3-dependent deacetylation of SOD2 plays a protective role against oxidative stress in oocytes from diabetic mice[J]. Cell Cycle, 2017, 16(13):1302-1308. [31] YU W, DITTENHAFER-REED K E, DENU J M. SIRT3 protein deacetylates isocitrate dehydrogenase 2(IDH2) and regulates mitochondrial redox status[J]. J Biol Chem, 2012, 287(17):14078-14086. |